Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease

U Mahadevan, MD Long, SV Kane, A Roy… - Gastroenterology, 2021 - Elsevier
Background & Aims Pregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …
被引用次数：191 相关文章

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.

U Mahadevan, MD Long, SV Kane, A Roy… - …, 2021 - escholarship.org
Background & aimsPregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.

U Mahadevan, MD Long, SV Kane, A Roy… - …, 2020 - europepmc.org
Methods Between 2007 and 2019, pregnant women with IBD were enrolled in a prospective,
observational, multicenter study across the United States. The primary analysis was a …
[HTML] nih.gov

[HTML][HTML] Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease

U Mahadevan, MD Long, SV Kane, A Roy… - …, 2021 - ncbi.nlm.nih.gov
Background Pregnant women with inflammatory bowel disease (IBD) may require biologic
or thiopurine therapy to control disease activity. Lack of safety data has led to therapy …

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

U Mahadevan, MD Long, SV Kane, A Roy… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background & aims Pregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

U Mahadevan, MD Long, SV Kane, A Roy… - …, 2021 - gastrojournal.org
Background & Aims Pregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …

[引用][C] Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

U Mahadevan, MD Long, SV Kane, A Roy… - Gastroenterology, 2021 - cir.nii.ac.jp
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among
Women With Inflammatory Bowel Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …